Peter J. Bostick

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

Peter J. Bostick, Sanjoy Chatterjee, D D et al. · Journal of Clinical Oncology · 1998 · 356 citations

Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma Patients

Peter J. Bostick, Donald L. Morton, Roderick R. Turner et al. · Journal of Clinical Oncology · 1999 · 270 citations

Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.

Bilchik Aj, A E Giuliano, Richard Essner et al. · PubMed · 1999 · 180 citations

Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.

Bret Taback, A. D. Chan, Christine Kuo et al. · PubMed · 2001 · 148 citations

Breast Oncology, Engineering, Molecular Markers +17

Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.

Dave S.�B. Hoon, Peter J. Bostick, Calvin Kuo et al. · PubMed · 2000 · 148 citations

Molecular Markers, Pathology, Cancer Registration +17